Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Introduction to the pharmacoeconomics of herbal medicines
Autore:
De Smet, PAGM; Bonsel, G; Van der Kuy, A; Hekster, YA; Pronk, MH; Brorens, MJA; Lockefeer, JHM; Nuijten, MJC;
Indirizzi:
Sci Inst Dutch Pharmacists, NL-2514 JL The Hague, Netherlands Sci Inst Dutch Pharmacists The Hague Netherlands NL-2514 JL Netherlands Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam, Netherlands Univ Amsterdam Amsterdam Netherlands & Biostat, Amsterdam, Netherlands Univ Hosp St Radboud, Nijmegen, Netherlands Univ Hosp St Radboud Nijmegen Netherlands adboud, Nijmegen, Netherlands Pronk Hlth Care Consultancy BV, Hilversum, Netherlands Pronk Hlth Care Consultancy BV Hilversum Netherlands ersum, Netherlands IZA, Nieuwegein, Netherlands IZA Nieuwegein NetherlandsIZA, Nieuwegein, Netherlands Medtap, Jisp, Netherlands Medtap Jisp NetherlandsMedtap, Jisp, Netherlands
Titolo Testata:
PHARMACOECONOMICS
fascicolo: 1, volume: 18, anno: 2000,
pagine: 1 - 7
SICI:
1170-7690(200007)18:1<1:ITTPOH>2.0.ZU;2-D
Fonte:
ISI
Lingua:
ENG
Soggetto:
BENIGN PROSTATIC HYPERPLASIA; COST-EFFECTIVENESS; TRICYCLIC ANTIDEPRESSANTS; ALTERNATIVE MEDICINE; UNITED-STATES; THERAPY; CARE; PREVALENCE; INFARCTION; TERAZOSIN;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
32
Recensione:
Indirizzi per estratti:
Indirizzo: De Smet, PAGM Sci Inst Dutch Pharmacists, Alexanderstr 11, NL-2514 JL The Hague, Netherlands Sci Inst Dutch Pharmacists Alexanderstr 11 The Hague Netherlands NL-2514 JL
Citazione:
P.A.G.M. De Smet et al., "Introduction to the pharmacoeconomics of herbal medicines", PHARMACOECO, 18(1), 2000, pp. 1-7

Abstract

This article explores the need to perform pharmacoeconomic evaluations of herbal medicines and assesses the extent to which this approach has been applied so far to these products. There seems to be no compelling need for pharmacoeconomic analyses of herbal over-the-counter medicines, but such analyses are certainly warranted for herbal prescription medicines that have a high level of reimbursement. Such preparations are used in Germany, in particular, where physicians prescribed ginkgo, hawthorn, St John's wort, horse-chestnut and saw palmetto to a value of more than DM50 million each in 1996. In our survey, only a single pharmacoeconomic study, of uncertain quality,was found on these 5 herbs, whereas several pharmacoeconomic reports on synthetic competitors were retrieved. The time has come to submit highly reimbursed herbal prescription medicines to the same rigorous pharmacoeconomic evaluations as their synthetic competitors. At present, such studies are particularly important for Germany, but in the future they may also become relevant for other countries, inside as well as outside Europe.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/04/20 alle ore 02:40:48